Chemours Announces Glycolic Acid Sustainability Program at In-Cosmetics Global Tradeshow

The long-term program is focused on significantly lowering the carbon footprint of Chemours’ glycolic acid grades by up to 80% against a 2023 baseline

WILMINGTON, Del.--(BUSINESS WIRE)-- The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced a long-term sustainability program for its glycolic acid product portfolio to address growing consumer demand for sustainable products at the 2023 in-cosmetics Global tradeshow. The sustainability program’s ultimate goal is to reduce the carbon footprint of all of Chemours’ glycolic acid grades by 80% against a 2023 baseline.

“The world increasingly expects companies to produce products responsibly and sustainably. At Chemours, we share those expectations. We are committed to driving more sustainable manufacturing processes that reduce the impact on the environment while providing our customers with the high-quality products they expect,” said James Kanicky, Chemical Solutions Global Business Director at Chemours. “Our goal to drive greater sustainability in producing our leading glycolic acid portfolio of products is aligned with our Corporate Responsibility Commitment (CRC) and our work to reduce our absolute greenhouse gas emissions by 60% by 2030, on a journey to net-zero by 2050.”

Chemours glycolic acid products include Glypure^™, a high-purity glycolic acid for personal care applications, which is one of the most popular active ingredients in anti-aging formulations, and Glyclean^™ D, a disinfection grade glycolic acid that delivers high antimicrobial efficacy as well as excellent cleaning and environmental properties.

The long-term sustainability program will address the three main phases contributing to the products’ carbon footprint. The first phase includes replacing fossil fuel-based electricity with renewable energy. The second will replace fossil fuel-derived carbon dioxide (CO₂) with renewably sourced or recycled CO₂. The final stage will replace petrochemical-based formaldehyde with syngas-based formaldehyde, a key raw material for glycolic acid formation.

Chemours will partner with its local electricity supplier to support the development of renewable energy programs in the West Virginia and Ohio region. These programs will supply Chemours with renewable energy credits from wind and solar power generators. Renewable Energy Credits (RECs) from the local projects will displace most of the Chemours Belle’s glycolic acid facility’s power-related carbon footprint and will start to be received in 2024 and fully available by mid to late 2025.

Chemours will spotlight its Glypure^™ portfolio at the 2023 in-cosmetics Global tradeshow at booth AL53 in Barcelona, Spain, from Mar. 28-30, 2023.

About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our flagship products are sold under prominent brands such as Ti-Pure^™, Opteon^™, Freon^™, Teflon^™, Viton^™, Nafion^™, and Krytox^™. The company has approximately 6,600 employees and 29 manufacturing sites serving approximately 2,900 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other

jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized, such as full year guidance relying on models based upon management assumptions regarding future events that are inherently uncertain. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets, which has had and we expect will continue to have a negative impact on our financial results. The full extent and impact of the pandemic is still being determined and to date has included significant volatility in financial and commodity markets and a severe disruption in economic activity. The public and private sector response has led to travel restrictions, temporary business closures, quarantines, stock market volatility, and interruptions in consumer and commercial activity globally. Matters outside our control, including general economic conditions, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2022. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230328005243/en/

INVESTORS

Jonathan Lock

SVP, Chief Development Officer

+1.302.773.2263

investor@chemours.com

Kurt Bonner

Manager, Investor Relations

+1.302.773.0026

investor@chemours.com

NEWS MEDIA

Thomas Sueta

Director, Corporate Communications

+1.302.773.3903

media@chemours.com

Source: The Chemours Company